Study of Bimatoprost Gel on Eyelash Growth

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Treatments: Bimatoprost

Criteria

Inclusion Criteria:

• 18-80 YO females

• madarosis or hypotrichosis (loss of eyelashes) due to chemotherapy used to treat breast cancer

• only breast cancer patients

Exclusion Criteria:

• inability to follow up, apply gel

• active eye/eyelid infection or inflammatory process

• cancer not related to breast cancer, healthy patients

• males